http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I722770-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7162e77c98aa0a641628b8d302beb412 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 |
| filingDate | 2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff5f964e30551d3c3c59dd26d861b60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b35c4627927aa4dc50a06d76f8f2c099 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e72bcb471dce2cb0a41940ab27529dd |
| publicationDate | 2021-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I722770-B |
| titleOfInvention | Method for producing secondary metabolites from neosartorya fischeri and use of the same in preparation of medicinal composition for inhibiting adenocarcinoma |
| abstract | The present invention relates to a method for producing secondary metabolites from Neosartorya fischeri and a use of the same in preparation of a medicinal composition for inhibiting adenocarcinoma. The aforementioned secondary metabolites include acetylaszonalenin or a crude extract containing acetylaszonalenin to inhibit activities of colorectal cancer cells in vitro. |
| priorityDate | 2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.